Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eric Paul Wehrenberg-Klee, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Tanaka M, Uppot R, Daye D, Liu R, Wehrenberg-Klee E. The double-balloon technique: a safe and effective adjunctive technique in patients undergoing arterial therapy for hepatic malignancies with vascular supply not amenable to selective administration. CVIR Endovasc. 2023 Feb 07; 6(1):3. PMID: 36746809; PMCID: PMC9902581.
    Citations:    
  2. Som A, Rosenboom JG, Chandler A, Sheth RA, Wehrenberg-Klee E. Image-guided intratumoral immunotherapy: Developing a clinically practical technology. Adv Drug Deliv Rev. 2022 10; 189:114505. PMID: 36007674.
    Citations: 1     Fields:    Translation:Humans
  3. Shuman AG, Aapro MS, Anderson B, Arbour K, Barata PC, Bardia A, Bruera E, Chabner BA, Chen H, Choy E, Conte P, Curigliano G, Dizon D, O'Reilly E, Tito Fojo A, Gelderblom H, Graubert TA, Gurtler JS, Hall E, Hirsch FR, Idbaih A, Ilson DH, Kelley M, La Vecchia C, Ludwig H, Moy B, Muss H, Opdam F, Pentz RD, Posner MR, Ross JS, Sacher A, Senan S, Perez de Celis ES, Tanabe KK, Vermorken JB, Wehrenberg-Klee E, Bates SE. Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization. Oncologist. 2022 Aug 13. PMID: 35962750; PMCID: PMC9438903.
    Citations:    Fields:    
  4. de Aguiar Ferreira C, Heidari P, Ataeinia B, Sinevici N, Granito A, Kumar HM, Wehrenberg-Klee E, Mahmood U. Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide. Pharmaceutics. 2022 Jul 13; 14(7). PMID: 35890355; PMCID: PMC9325142.
    Citations: 1     
  5. Bertolet A, Wehrenberg-Klee E, Bobic M, Grassberger C, Perl J, Paganetti H, Schuemann J. Pre- and post-treatment image-based dosimetry in90Y-microsphere radioembolization using the TOPAS Monte Carlo toolkit. Phys Med Biol. 2021 12 29; 66(24). PMID: 34915451; PMCID: PMC8729171.
    Citations:    Fields:    Translation:Humans
  6. Wehrenberg-Klee E, Goyal L. Combining systemic and local therapies for hepatocellular carcinoma. Lancet Gastroenterol Hepatol. 2021 12; 6(12):976-978. PMID: 34695376.
    Citations:    Fields:    Translation:Humans
  7. Ferreira CA, Heidari P, Ataeinia B, Sinevici N, Sise ME, Colvin RB, Wehrenberg-Klee E, Mahmood U. Non-invasive Detection of Immunotherapy-Induced Adverse Events. Clin Cancer Res. 2021 10 01; 27(19):5353-5364. PMID: 34253581; PMCID: PMC8752648.
    Citations: 5     Fields:    Translation:HumansAnimals
  8. Som A, Reid NJ, DiCapua J, Cochran RL, An T, Uppot R, Zurkiya O, Wehrenberg-Klee E, Kalva S, Arellano RS. Microwave Ablation as Bridging Therapy for Patients with Hepatocellular Carcinoma Awaiting Liver Transplant: A Single Center Experience. Cardiovasc Intervent Radiol. 2021 Nov; 44(11):1749-1754. PMID: 34231009.
    Citations: 1     Fields:    Translation:Humans
  9. Wehrenberg-Klee E, Sinevici N, Nesti S, Kalomeris T, Austin E, Larimer B, Mahmood U. HER3 PET Imaging Identifies Dynamic Changes in HER3 in Response to HER2 Inhibition with Lapatinib. Mol Imaging Biol. 2021 12; 23(6):930-940. PMID: 34101105; PMCID: PMC8578458.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  10. Wu V, Li MD, Goodwin JS, Wehrenberg-Klee EP, Zurkiya O, Kalva SP, Ganguli S. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location. AJR Am J Roentgenol. 2021 11; 217(5):1141-1152. PMID: 33594907.
    Citations:    Fields:    Translation:Humans
  11. Leppelmann KS, Mooradian MJ, Ganguli S, Uppot RN, Yamada K, Irani Z, Wehrenberg-Klee EP, Zubiri L, Reynolds KL, Arellano RS, Hirsch JA, Sullivan RJ, Fintelmann FJ. Thermal Ablation, Embolization, and Selective Internal Radiation Therapy Combined with Checkpoint Inhibitor Cancer Immunotherapy: Safety Analysis. J Vasc Interv Radiol. 2021 02; 32(2):187-195. PMID: 33353814.
    Citations: 10     Fields:    Translation:Humans
  12. Bulman JC, Zurkiya O, Wu V, Wehrenberg-Klee E, Palmer E, Chow D, Brook A, Ganguli S. Repeat Evaluation of Lung Shunt Fraction is Unnecessary: A Retrospective Observational Study of Successive Lung Shunt Fractions from Variable Arterial Distributions in Patients Undergoing Radioembolization of Primary and Secondary Liver Tumors. J Vasc Interv Radiol. 2021 03; 32(3):412-418. PMID: 33341340.
    Citations:    Fields:    Translation:Humans
  13. Liu J, Sun X, Ganguli S, Wehrenberg-Klee EP, Bhan I, Zhao Y, Zhao L, Meng K, Sun R, Yu H, Sun G. Partial splenic embolization is superior to intravenous somatostatin for decreasing portal pressure in cirrhotic patients: a dynamic self-controlled cohort study. Scand J Gastroenterol. 2020 Nov; 55(11):1341-1346. PMID: 33076704.
    Citations: 2     Fields:    Translation:Humans
  14. Liu J, Wehrenberg-Klee EP, Bethea ED, Uppot RN, Yamada K, Ganguli S. Transjugular Intrahepatic Portosystemic Shunt Placement for Portal Hypertension: Meta-Analysis of Safety and Efficacy of 8?mm vs. 10?mm Stents. Gastroenterol Res Pract. 2020; 2020:9149065. PMID: 33123192; PMCID: PMC7586157.
    Citations: 5     
  15. Bent EH, Wehrenberg-Klee E, Koay EJ, Goyal L, Wo JY. Integration of Systemic and Liver-Directed Therapies for Locally Advanced Hepatocellular Cancer: Harnessing Potential Synergy for New Therapeutic Horizons. J Natl Compr Canc Netw. 2021 May; 19(5):567-576. PMID: 34030132.
    Citations: 2     Fields:    Translation:Humans
  16. LaSalle T, Austin EE, Rigney G, Wehrenberg-Klee E, Nesti S, Larimer B, Mahmood U. Granzyme B PET imaging of immune-mediated tumor killing as a tool for understanding immunotherapy response. J Immunother Cancer. 2020 05; 8(1). PMID: 32461343.
    Citations: 13     Fields:    Translation:HumansAnimals
  17. Li MD, Chu KF, DePietro A, Wu V, Wehrenberg-Klee E, Zurkiya O, Liu RW, Ganguli S. Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres. J Vasc Interv Radiol. 2019 03; 30(3):314-319. PMID: 30819470.
    Citations: 7     Fields:    Translation:Humans
  18. Wehrenberg-Klee E, Gandhi RT, Ganguli S. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma. Tech Vasc Interv Radiol. 2019 Jun; 22(2):70-73. PMID: 31079713.
    Citations: 6     Fields:    Translation:Humans
  19. Larimer BM, Bloch E, Nesti S, Austin EE, Wehrenberg-Klee E, Boland G, Mahmood U. The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging. Clin Cancer Res. 2019 02 15; 25(4):1196-1205. PMID: 30327313; PMCID: PMC6377844.
    Citations: 44     Fields:    Translation:HumansAnimalsCells
  20. Shao H, McCarthy C, Wehrenberg-Klee E, Thabet A, Uppot R, Dawson S, Arellano RS. CT-Guided Percutaneous Needle Biopsy of Retroperitoneal and Pelvic Lymphadenopathy: Assessment of Technique, Diagnostic Yield, and Clinical Value. J Vasc Interv Radiol. 2018 10; 29(10):1429-1436. PMID: 30174157.
    Citations: 5     Fields:    Translation:Humans
  21. Wehrenberg-Klee E, Goyal L, Dugan M, Zhu AX, Ganguli S. Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. 2018 Nov; 41(11):1799-1802. PMID: 29845347.
    Citations: 19     Fields:    Translation:Humans
  22. Larimer BM, Phelan N, Wehrenberg-Klee E, Mahmood U. Phage Display Selection, In Vitro Characterization, and Correlative PET Imaging of a Novel HER3 Peptide. Mol Imaging Biol. 2018 04; 20(2):300-308. PMID: 28733706.
    Citations: 9     Fields:    Translation:AnimalsCells
  23. Larimer BM, Wehrenberg-Klee E, Dubois F, Mehta A, Kalomeris T, Flaherty K, Boland G, Mahmood U. Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response. Cancer Res. 2017 05 01; 77(9):2318-2327. PMID: 28461564; PMCID: PMC5474226.
    Citations: 127     Fields:    Translation:HumansAnimalsCells
  24. Larimer BM, Wehrenberg-Klee E, Caraballo A, Mahmood U. Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy. J Nucl Med. 2016 Oct; 57(10):1607-1611. PMID: 27230929; PMCID: PMC5367446.
    Citations: 62     Fields:    Translation:AnimalsCells
  25. Wehrenberg-Klee E, Turker NS, Heidari P, Larimer B, Juric D, Baselga J, Scaltriti M, Mahmood U. Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance. J Nucl Med. 2016 09; 57(9):1413-9. PMID: 27081168; PMCID: PMC5093919.
    Citations: 17     Fields:    Translation:HumansCells
  26. Wehrenberg-Klee E, Redjal N, Leece A, Turker NS, Heidari P, Shah K, Mahmood U. PET imaging of glioblastoma multiforme EGFR expression for therapeutic decision guidance. Am J Nucl Med Mol Imaging. 2015; 5(4):379-89. PMID: 26269775; PMCID: PMC4529591.
    Citations: 8     
  27. Heidari P, Wehrenberg-Klee E, Habibollahi P, Yokell D, Kulke M, Mahmood U. Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization. Cancer Res. 2013 Dec 01; 73(23):6865-73. PMID: 24080280.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  28. Truesdale CM, Soulen MC, Clark TW, Mondschein JI, Wehrenberg-Klee E, Malkowicz SB, Wein AJ, Guzzo TJ, Stavropoulos SW. Percutaneous computed tomography-guided renal mass radiofrequency ablation versus cryoablation: doses of sedation medication used. J Vasc Interv Radiol. 2013 Mar; 24(3):347-50. PMID: 23433410.
    Citations: 7     Fields:    Translation:Humans
  29. Wehrenberg-Klee E, Stavropoulos SW. Inferior vena cava filters for primary prophylaxis: when are they indicated? Semin Intervent Radiol. 2012 Mar; 29(1):29-35. PMID: 23450194.
    Citations: 6     
  30. Wehrenberg-Klee E, Clark TW, Malkowicz SB, Soulen MC, Wein AJ, Mondschein JI, Van Arsdalen K, Guzzo TJ, Stavropoulos SW. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol. 2012 Jan; 23(1):41-5. PMID: 22019179.
    Citations: 9     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Wehrenberg-Klee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (128)
Explore
_
Co-Authors (47)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.